Judge upholds $327 million verdict over Johnson & Johnson’s Risperdal claims

    Johnson & Johnson could follow through with plans to appeal now that a South Carolina judge has upheld a $327 million verdict against the company for its claims about bipolar drug Risperdal.

    The civil penalty was handed down in March when the company was found guilty of overstating the safety and effectiveness of the drug compared with its competitors. As the Associated Press reports, this isn’t the only pending Risperdal case the company has.
    J&J argues it didn’t violate the South Carolina Unfair Trade Practices Act, but the Spartanburg Court of Common Pleas found such a violation did occur when the company gave doctors deceptive information about the drug.

    • WHYY thanks our sponsors — become a WHYY sponsor

    WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    Together we can reach 100% of WHYY’s fiscal year goal